A mouse model of carcinoid syndrome and heart disease

Journal of Surgical Research

Volumn 126, Issue 1, 2005, Pages 102-105

  Musunuru, Sandeepa ^a   Carpenter, Jennifer E ^a   Sippel, Rebecca S ^a   Kunnimalaiyaan, Muthusamy ^a   Chen, Herbert ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Animal model; Carcinoid; Carcinoid heart disease; Serotonin

Indexed keywords

CHROMOGRANIN A; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CARCINOID SYNDROME; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROSIS; HEART DISEASE; HEART VALVE; LIVER; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROTONIN BLOOD LEVEL; SEROTONIN RELEASE; STAINING; THROMBOCYTE; TISSUE SECTION; TRICUSPID VALVE; TUMOR CELL;

ANIMALS; CARCINOID HEART DISEASE; DISEASE MODELS, ANIMAL; HYDROXYINDOLEACETIC ACID; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; SEROTONIN;

EID: 19444370501     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jss.2005.01.003     Document Type: Article

References (18)

1. M. Kulke, R. Mayer Carcinoid tumors N. Engl. J. Med. 340 1999 858
2. J. Moller, H. Connolly, J. Rubin Factors associated with progression of carcinoid heart disease N. Engl. J. Med. 348 2003 1005
3. R. Sippel, H. Chen An update on carcinoid tumors Problems Gen. Surg. 20 2003 125
4. J. Mansour, H. Chen Research review Pancreatic endocrine tumors J. Surg. Res. 120 2004 139
5. J. Van Gompel, R. Sippel, T. Warner Gastrointestinal carcinoid tumors Factors that predict outcome World J. Surg. 28 2004 387
6. R. Sutcliffe, D. Maguire, J. Ramage Management of neuroendocrine liver metastases Am. J. Surg. 187 2004 39
7. A. Anderson, D. Kraus, R. Lang Cardiovascular complications of malignant carcinoid disease Am. Heart J. 134 1997 693
8. H. Connolly Carcinoid heart disease Medical and surgical considerations Cancer Control 8 2001 454
9. W. Roberts A unique heart disease associated with a unique cancer Carcinoid heart disease Am. J. Cardiol. 80 1997 251
10. L. Lundin, I. Norheim, J. Landelius Carcinoid heart disease Relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities Circulation 77 1988 264
11. P. Robiolio, V. Rigolin, J. Wilson Carcinoid heart disease Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography Circulation 92 1995 790
12. J. Zuetenhorst, J. Bonfrer, C. Korse Carcinoid heart disease The role of urinary 5-hydroxyindoleacetic acid excretion and plasma levels of atrial natriuretic peptide, transforming growth factor-β and fibroblast growth factor Cancer 97 2003 1609
13. W. Denney, E. Kemp, L. Anthony Echocardiographic and biochemical evaluation of the development and progression of carcinoid heart disease J. Am. Coll. Cardiol. 32 1998 1017
14. B. Jian, J. Xu, J. Connolly Serotonin mechanisms in heart valve disease I Serotonin-induced up-regulation of transforming growth factor-β-G-protein signal transduction in aortic valve interstitial cells Am. J. Pathol. 161 2002 2111
15. P. Pellikka, A. Tajik, B. Khandheria Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients Circulation 87 1993 1188
16. R. Himelman, N. Schiller Clinical and echocardiographic comparison of patients with the carcinoid syndrome with and without carcinoid heat disease Am. J. Cardiol. 63 1998 347
17. R. Sippel, J. Carpenter, M. Kunnimalaiyaan Raf-1 activation suppresses neuroendocrine marker and hormone levels in human gastrointestinal carcinoid cells Am. J. Physiol. Gastrointest. Liver Physiol. 285 2003 G245
18. R. Sippel, H. Chen Activation of the ras/raf-1 signal transduction pathway in carcinoid tumor cells results in morphologic transdifferentiation Surgery 132 2002 1035